Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
or
Menu

Atossa Genetics Inc (ATOS)

[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (BATS)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ fieldTitles[key] ]] [[ value ]] [[ value ]]
Realtime quote and/or trades are not sourced from all markets.

Fundamentals

See More
  • Market Capitalization, $K 8,221
  • Shares Outstanding, K 26,520
  • Annual Sales, $ 0 K
  • Annual Income, $ -6,370 K
  • 36-Month Beta 1.29
  • Price/Sales N/A
  • Price/Cash Flow N/A
  • Price/Book 1.81
  • Price/Earnings ttm 0.00
  • Earnings Per Share ttm -2.03
  • Most Recent Earnings N/A on N/A
  • Next Earnings Date 11/13/17
  • Annual Dividend & Yield 0.00 (0.00%)
  • Most Recent Dividend N/A on N/A
  • Sectors:

Price Performance

See More
Period Period Low Period High Performance
1-Month
0.28 +10.71%
on 12/08/17
0.40 -21.52%
on 11/13/17
-0.06 (-16.22%)
since 11/10/17
3-Month
0.28 +10.71%
on 12/08/17
1.59 -80.50%
on 10/25/17
-0.47 (-60.26%)
since 09/12/17
52-Week
0.28 +10.71%
on 12/08/17
1.85 -83.24%
on 02/09/17
-1.30 (-80.75%)
since 12/12/16

Most Recent Stories

More News
Blog Exposure - Neogen's Shareholders Set to Receive Additional Stock as the Company Announces Stock Split

Stock Monitor: Atossa Genetics Post Earnings Reporting

ATOS : 0.31 (-6.06%)
NEOG : 79.91 (+0.95%)
Technical Perspectives on Palatin Technologies, Atossa Genetics, DBV Technologies, and IDEXX Labs

In keeping with the commitment to dynamically provide members with timely information, WallStEquities.com has issued free tailored Stock Review on PTN, ATOS, DBVT, and IDXX which is a click away at http://www.wallstequities.com/registration....

DBVT : 21.21 (-0.42%)
ATOS : 0.31 (-6.06%)
IDXX : 159.27 (-0.27%)
PTN : 0.84 (-1.06%)
Report: Exploring Fundamental Drivers Behind NRG Energy, Foot Locker, Campbell Soup, Atossa Genetics, Gentex, and Genworth Financial -- New Horizons, Emerging Trends, and Upcoming Developments

In new independent research reports released early this morning, Fundamental Markets released its latest key findings for all current investors, traders, and shareholders of NRG Energy, Inc. (NYSE:NRG),...

GNW : 3.38 (-0.59%)
NRG : 28.70 (-1.48%)
CPB : 49.76 (+2.49%)
FL : 44.57 (+0.36%)
ATOS : 0.31 (-6.06%)
GNTX : 20.52 (+0.54%)
"Will the Bull Market Continue to Run?"

SAN FRANCISCO, CA / ACCESSWIRE / November 29, 2017 / Vista Partners ("Vista") has published November's FREE Macroeconomic & Investment Monthly Newsletter, "Will the Bull Market Continue to Run?"

ATOS : 0.31 (-6.06%)
FSNN : 3.87 (-1.78%)
Edison Issues Outlook on Atossa Genetics (ATOS)

LONDON, UK / ACCESSWIRE / November 16, 2017 / Atossa Genetics (NASDAQ: ATOS) reported Phase I data on its topical endoxifen formulation and it is now developing this as a potential treatment for high mammographic...

ATOS : 0.31 (-6.06%)
Atossa Genetics Announces Third Quarter 2017 Financial Results And Provides Company Update

Atossa Genetics Inc. (NASDAQ:ATOS) ("Atossa" or the "Company"), a clinical-stage pharmaceutical company developing novel therapeutics and delivery methods for breast cancer and other breast conditions,...

ATOS : 0.31 (-6.06%)
Atossa Genetics Applauds Newly-Introduced Federal Legislation Requiring That Breast Density Be Reported To Physicians and Patients

Atossa Genetics Inc. (NASDAQ:ATOS), a clinical-stage pharmaceutical company developing novel therapeutics and delivery methods for breast cancer and other breast conditions, today announced its support...

ATOS : 0.31 (-6.06%)
"Economy Still Growing Strong?"

SAN FRANCISCO, CA / ACCESSWIRE / October 31, 2017 / Vista Partners ("Vista") has published October's FREE Macroeconomic & Investment Monthly Newsletter, "Economy Still Growing Strong?"

ATOS : 0.31 (-6.06%)
FSNN : 3.87 (-1.78%)
Atossa Genetics Announces Closing of $5.5 Million Common Stock Public Offering and Over-allotment Option

Atossa Genetics Inc. (NASDAQ:ATOS) ("Atossa" or the "Company"), a clinical-stage pharmaceutical company developing novel therapeutics and delivery methods for breast cancer and other breast conditions,...

ATOS : 0.31 (-6.06%)
Atossa Genetics Announces Pricing of $5.1 Million Public Offering of Common Stock

Atossa Genetics Inc. (NASDAQ:ATOS) ("Atossa" or the "Company"), a clinical-stage pharmaceutical company developing novel therapeutics and delivery methods for breast cancer and other breast conditions,...

ATOS : 0.31 (-6.06%)

Barchart Technical Opinion

The Barchart Technical Opinion rating is a 72% Sell with a Average short term outlook on maintaining the current direction.

Longer term, the trend strength is Average. Long term indicators fully support a continuation of the trend.

See More

Business Summary

Atossa Genetics Inc. is a healthcare company focused on the development and marketing of cellular and molecular diagnostic risk assessment products for breast cancer. The Company's diagnostic tests consist of medical devices which can collect fluid samples from the breast milk ducts. It is also conducting...

See More

Key Turning Points

2nd Resistance Point 0.35
1st Resistance Point 0.33
Last Price 0.31
1st Support Level 0.30
2nd Support Level 0.29

See More

52-Week High 1.85
Fibonacci 61.8% 1.25
Fibonacci 50% 1.07
Fibonacci 38.2% 0.88
Last Price 0.31
52-Week Low 0.28

See More

Add Data Columns to this Table
Learn about our Custom Views
Want to use this as
your default charts setting?
Learn about our Custom Templates
Switch the Market flag
above for targeted data.
Open the menu and switch the
Market flag for targeted data.
Get Streaming Chart Updates
Switch your Site Preferences
to Interactive Chart
New Chart Menu
Right-click anywhere on the chart to open the Interactive Chart menu.